Intestinal D-galactose transport in an endotoxemia model in the rabbit

被引:30
作者
Amador, P.
Garcia-Herrera, J.
Marca, M. C.
de la Osada, J.
Acin, S.
Navarro, M. A.
Salvador, M. T.
Lostao, M. P.
Rodriguez-Yoldi, M. J.
机构
[1] Univ Zaragoza, Fac Vet, Dept Pharmacol & Physiol, Physiol Unit, E-50013 Zaragoza, Spain
[2] Univ Zaragoza, Fac Vet, Dept Biochem & Mol Biol, Biochem Unit, E-50013 Zaragoza, Spain
[3] Univ Navarra, Dept Physiol & Nutr, E-31008 Pamplona, Spain
[4] Univ Zaragoza, Fac Vet, Dept Anim Pathol, Internal Med Unit, E-50013 Zaragoza, Spain
关键词
lipopolysaccharide; mitogen-activated protein kinase; protein kinase A; protein kinase C; Proteasome; Na+/glucose cotransporter 1;
D O I
10.1007/s00232-007-9012-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipopolysaccharide ( LPS) is an endotoxin causing sepsis. Studies from our laboratory revealed impaired intestinal absorption of L- leucine and D- fructose in LPS- treated rabbits. The aim of this study was to examine intestinal D- galactose transport following intravenous administration of LPS in the rabbit and to identify the cellular mechanisms driving this process. Endotoxin treatment diminished the buildup of D- galactose in intestinal tissue, the mucosal to serosal transepithelial flux of the sugar and its uptake by brush border membrane vesicles ( BBMVs). Intracellular signaling pathways associated with protein kinase C ( PKC), protein kinase A ( PKA), p38 mitogen- activated protein kinase ( p38MAPK), Jun N- terminal kinase ( JNK), MAPK/ extracellular signalregulated kinases 1 and 2 ( MEK1/ 2) and proteasome were found to be involved in this reduction in sugar uptake. Na+/ glucose cotransporter 1 ( SGLT1) protein levels in BBMVs were lower for LPS- treated animals than control animals. These findings indicate that LPS inhibits the intestinal absorption of D- galactose via a complex cellular mechanism that could involve posttranscriptional regulation of the SGLT1 transporter.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 49 条
  • [1] Tumor necrosis factor-α mediates inhibitory effect of lipopolysaccharide on L-leucine intestinal uptake
    Abad, B
    Mesonero, JE
    Salvador, MT
    Garcia-Herrera, J
    Rodriguez-Yoldi, MJ
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (06) : 1316 - 1322
  • [2] The administration of lipopolysaccharide, in vivo, induces alteration in L-leucine intestinal absorption
    Abad, B
    Mesonero, JE
    Salvador, MT
    Herrera, JG
    Rodríguez-Yoldi, MJ
    [J]. LIFE SCIENCES, 2001, 70 (06) : 615 - 628
  • [3] Cellular mechanism underlying LPS-induced inhibition of in vitro L-leucine transport across rabbit jejunum
    Abad, B
    Mesonero, JE
    Salvador, MT
    García-Herrera, J
    Rodríguez-Yoldi, MJ
    [J]. JOURNAL OF ENDOTOXIN RESEARCH, 2002, 8 (02): : 127 - 133
  • [4] Effect of lipopolysaccharide on small intestinal L-leucine transport in rabbit
    Abad, B
    Mesonero, JE
    Salvador, MT
    Garcia-Herrera, J
    Rodriguez-Yoldi, MJ
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (05) : 1113 - 1119
  • [5] Clinical update: Novel targets in multiple myeloma
    Anderson, KC
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 27 - 32
  • [6] Aw TY, 1999, AM J CLIN NUTR, V70, P557
  • [7] SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
    Bennett, BL
    Sasaki, DT
    Murray, BW
    O'Leary, EC
    Sakata, ST
    Xu, WM
    Leisten, JC
    Motiwala, A
    Pierce, S
    Satoh, Y
    Bhagwat, SS
    Manning, AM
    Anderson, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13681 - 13686
  • [8] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [9] BROTLAROCHE E, 1986, J BIOL CHEM, V261, P6168
  • [10] CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION
    BROWN, K
    GERSTBERGER, S
    CARLSON, L
    FRANZOSO, G
    SIEBENLIST, U
    [J]. SCIENCE, 1995, 267 (5203) : 1485 - 1488